TISSUE FACTOR IN PLASMA OF PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION

被引:43
作者
TAKAHASHI, H [1 ]
SATOH, N [1 ]
WADA, K [1 ]
TAKAKUWA, E [1 ]
SEKI, Y [1 ]
SHIBATA, A [1 ]
机构
[1] NIIGATA UNIV,SCH MED,DEPT INTERNAL MED 1,NIIGATA,JAPAN
关键词
DIC; PLASMA TISSUE FACTOR ANTIGEN; BLOOD COAGULATION ACTIVATION; LEUKEMIA; CANCER;
D O I
10.1002/ajh.2830460414
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recently it has been shown that tissue factor (TF), an important trigger for initiating blood coagulation, is present in the circulating plasma. In order to assess the clinical implications of TF in plasma, plasma concentration of TF was quantitated in 65 patients with disseminated intravascular coagulation (DIC). The mean concentration of plasma TF was elevated in patients with DIC at presentation as compared with healthy subjects (446 +/- SD 536 pg/ml vs. 138 +/- 51 pg/ml, P < 0.001). Abnormally high levels were found only in 46.2% of the patients, predominantly in patients with non-hematological solid tumors and acute leukemia. Plasma TF did not correlate with hemostatic markers of DIC such as thrombin-antithrombin III complex, prothrombin fragment 1+2, plasmin-alpha(2)-plasmin inhibitor complex, FDP, D-dimer, or fibrinogen. Serial determinations of plasma TF demonstrated that plasma TF changes roughly in parallel with the course of DIC in most patients with elevated TF at presentation of DIC. These findings suggest that plasma TF is potentially valuable for monitoring the progress of DIC in a limited population of patients. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:333 / 337
页数:5
相关论文
共 50 条
[31]   Laboratory testing in disseminated intravascular coagulation [J].
Toh, CH .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2001, 27 (06) :653-656
[32]   Disseminated Intravascular Coagulation in Cancer: An Update [J].
Levi, Marcel .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2019, 45 (04) :342-347
[33]   Disseminated intravascular coagulation in solid tumours [J].
Ferrand, Francois Regis ;
Garcia-Hejl, Carine ;
Moussaid, Yassine ;
Schernberg, Antoine ;
Bidard, Francois-Clement ;
Pavic, Michel ;
Khenifer, Safia ;
Stoclin, Annabelle .
BULLETIN DU CANCER, 2014, 101 (06) :580-592
[34]   Disseminated intravascular coagulation: Testing and diagnosis [J].
Wada, Hideo ;
Matsumoto, Takeshi ;
Yamashita, Yoshiki ;
Hatada, Tsuyoshi .
CLINICA CHIMICA ACTA, 2014, 436 :130-134
[35]   Laboratory Testing in Disseminated Intravascular Coagulation [J].
Favaloro, Emmanuel J. .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2010, 36 (04) :458-467
[36]   Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation [J].
Watanabe, R ;
Wada, H ;
Watanabe, Y ;
Sakakura, M ;
Nakasaki, T ;
Mori, Y ;
Nishikawa, M ;
Gabazza, EC ;
Nobori, T ;
Shiku, H .
THROMBOSIS RESEARCH, 2001, 104 (01) :1-6
[37]   Plasma sFas and sFas ligand levels in patients with thrombotic thrombocytopenic purpura and in those with disseminated intravascular coagulation [J].
Hori, Y ;
Wada, H ;
Mori, Y ;
Shimura, M ;
Hiyoyama, K ;
Nakasaki, T ;
Nishii, K ;
Tamaki, S ;
Nishikawa, M ;
Deguchi, K ;
Minami, N ;
Shiku, H .
AMERICAN JOURNAL OF HEMATOLOGY, 1999, 61 (01) :21-25
[38]   Factor VIIa-AT Complex Is an Independent Prognostic Marker of Disseminated Intravascular Coagulation [J].
Lee, Joon Hee ;
Gu, JaYoon ;
Kim, Hyun Kyung .
ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2021, 51 (04) :546-551
[39]   THE EFFECT OF 2-DOMAIN TISSUE FACTOR PATHWAY INHIBITOR ON ENDOTOXIN-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION IN RABBITS [J].
BREGENGARD, C ;
NORDFANG, O ;
WILDGOOSE, P ;
SVENDSEN, O ;
HEDNER, U ;
DINESS, V .
BLOOD COAGULATION & FIBRINOLYSIS, 1993, 4 (05) :699-706
[40]   Performances of disseminated intravascular coagulation scoring systems in septic shock patients [J].
Helms, Julie ;
Severac, Francois ;
Merdji, Hamid ;
Clere-Jehl, Raphael ;
Francois, Bruno ;
Mercier, Emmanuelle ;
Quenot, Jean-Pierre ;
Meziani, Ferhat .
ANNALS OF INTENSIVE CARE, 2020, 10 (01)